[{"orgOrder":0,"company":"AVVA Pharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CYPRUS","productType":"Miscellaneous","year":"2025","type":"Inapplicable","leadProduct":"Clotrimazole","moa":"Cytochrome P450 51","graph1":"Infections and Infectious Diseases","graph2":"Phase II\/ Phase III","graph3":"AVVA Pharma","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Suppository","sponsorNew":"AVVA Pharma \/ Undisclosed","highestDevelopmentStatusID":"9","companyTruncated":"AVVA Pharma \/ Undisclosed"},{"orgOrder":0,"company":"Avva Rus JSC","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Antibiotic","year":"2024","type":"Inapplicable","leadProduct":"Natamycin","moa":"Ergosterol","graph1":"Infections and Infectious Diseases","graph2":"Phase III","graph3":"Avva Rus JSC","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Suppository","sponsorNew":"Avva Rus JSC \/ Undisclosed","highestDevelopmentStatusID":"10","companyTruncated":"Avva Rus JSC \/ Undisclosed"},{"orgOrder":0,"company":"AVVA Pharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Psychiatry\/Psychology","country":"CYPRUS","productType":"Plant Extract\/Herbal","year":"2023","type":"Inapplicable","leadProduct":"Alcofiltrum","moa":"Undisclosed","graph1":"Psychiatry\/Psychology","graph2":"Undisclosed","graph3":"AVVA Pharma","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Psychiatry","amount2New":0,"dosageForm":"Tablet","sponsorNew":"AVVA Pharma \/ Undisclosed","highestDevelopmentStatusID":"1","companyTruncated":"AVVA Pharma \/ Undisclosed"},{"orgOrder":0,"company":"Avva Rus JSC","sponsor":"Kirov State Medical Academy | Kirov Regional Clinical Center of Perinatology","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Probiotic","year":"2010","type":"Inapplicable","leadProduct":"Lactofiltrum","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase II\/ Phase III","graph3":"Avva Rus JSC","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Avva Rus JSC \/ Kirov State Medical Academy | Kirov Regional Clinical Center of Perinatology","highestDevelopmentStatusID":"9","companyTruncated":"Avva Rus JSC \/ Kirov State Medical Academy | Kirov Regional Clinical Center of Perinatology"},{"orgOrder":0,"company":"Avva Rus JSC","sponsor":"Moscow State University of Medicine and Dentistry | Moscow Dermatovenerologic Clinical Dispensary","pharmaFlowCategory":"DU","therapeuticArea":"Dermatology","country":"RUSSIA","productType":"Probiotic","year":"2010","type":"Inapplicable","leadProduct":"Lactofiltrum","moa":"Undisclosed","graph1":"Dermatology","graph2":"Phase II\/ Phase III","graph3":"Avva Rus JSC","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Avva Rus JSC \/ Moscow State University of Medicine and Dentistry | Moscow Dermatovenerologic Clinical Dispensary","highestDevelopmentStatusID":"9","companyTruncated":"Avva Rus JSC \/ Moscow State University of Medicine and Dentistry | Moscow Dermatovenerologic Clinical Dispensary"},{"orgOrder":0,"company":"Avva Rus JSC","sponsor":"St. Vladimir Moscow Children's Clinical Hospital | Arhangelsk Regional Children's Clinical Hospital named after Vizshletsov P.G.","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"RUSSIA","productType":"Undisclosed","year":"2010","type":"Inapplicable","leadProduct":"Lignin Hydrolytic","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase II\/ Phase III","graph3":"Avva Rus JSC","amount2":0,"highestDevelopmentShortName":"Ph II\/III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Avva Rus JSC \/ St. Vladimir Moscow Children's Clinical Hospital | Arhangelsk Regional Children's Clinical Hospital named after Vizshletsov P.G.","highestDevelopmentStatusID":"9","companyTruncated":"Avva Rus JSC \/ St. Vladimir Moscow Children's Clinical Hospital | Arhangelsk Regional Children's Clinical Hospital named after Vizshletsov P.G."}]

Find Clinical Drug Pipeline Developments & Deals by AVVA Pharma

AVVA Pharma
Drugs in Dev.
Full Screen View

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

cayman pipeline prospector

Contact Supplier

Check all FDF Dossiers for
this supplier

Contact Us
PharmaScopic.com

AVVA Pharma

VISIT THE VIRTUAL BOOTH, Contact Details

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

FINISHED DOSAGE FORMULATIONS

32 FDF Dossiers, 32 Listed Dossiers

Xls

Filters

×

filter

Company Name

filter

Year

filter

DEALS // DEV.

filter

Country

filter

Sponsor

filter

Therapeutic Area

filter

Study Phase

filter

Deal Type

filter

Product Type

filter

Dosage Form

filter

Lead Product

filter

Target

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

AVVA Pharma

Cyprus

AIChE Annual Meeting

Not Confirmed

02

Avva Rus JSC

Russia

AIChE Annual Meeting

Not Confirmed

03

AVVA Pharma

Cyprus

AIChE Annual Meeting

Not Confirmed

04

Avva Rus JSC

Russia

AIChE Annual Meeting

Not Confirmed

05

Avva Rus JSC

Russia

AIChE Annual Meeting

Not Confirmed

06

Avva Rus JSC

Russia

AIChE Annual Meeting

Not Confirmed